Long-term Anticoagulant Therapy with Warfarin and its Risks and Pitfalls in Old Age
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00063457" target="_blank" >RIV/00216224:14110/12:00063457 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Long-term Anticoagulant Therapy with Warfarin and its Risks and Pitfalls in Old Age
Original language description
Warfarin is a frequently used anticoagulant therapy (AT) in clinical practice for elderly patients at risk of thromboembolism (venous or arterial) as well as for those with established thromboembolism. Bleeding is the most common complication of long-term warfarin therapy. The risk of bleeding is directly influenced by intensity of anticoagulant therapy, age, renal insufficiency, and latent disease of the gastrointestinal and genitourinary tracts. Conclusions: Most elderly patients in need of prolongedanticoagulation can be treated safely and effectively with warfarin if treatment includes education, meticulous attention to comorbid illnesses and concomitant drugs, and dose monitoring through a coordinated anticoagulant program.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů